Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
ALXN2050 for Myasthenia Gravis
Recruiting0 awardsPhase 2
Westchester, Ohio
This trial is testing a medication called ALXN2050 to see if it helps people with generalized myasthenia gravis, a condition that causes muscle weakness. The study will monitor safety and effectiveness over time and includes a phase where all participants will receive the medication.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service